Beth J Hoffman, PhD

Beth J Hoffman, PhD

Company: Origami Therapeutics Inc

Job title: President & CEO


Fireside Chat: Using 3D Models to Guide Biomarker & Patient Stratification 2:15 pm

Hear from industry leaders delving into how to utilize 3D Models to guide direct biomarkers or that you can immediately apply to your model and for patient stratification How do you find a biomarker that will give you the same indication that you are looking at but is also applicable to your model? How are…Read more

day: Day Two

Modeling Adult Diseases Using iPSCs – Is It Possible? 4:00 pm

 How can we use iPSCs to understand adult disease? What can we learn from iPSC-derived models that are not phenotypically / functionally mature – the fetal gene signature Discuss the use of iPSCs to develop 3D tissue models How can we meet the challenge of statistical power in the face of remarkable differences between patient-derived…Read more

day: Track A - Day 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.